Acute myocardial infarction. ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
Conditions
Interventions
Intervention 1: Clopidogrel plus Ebtifibatide
patients with STEMI that candidate for primary PCI were divided in tow groups of clopidogrel+eptifibatide and ticagrelor. No reflow phenomen after pci was evaluated in two groups. Intervention 2: Inte
Patients with STEMI that candidate for primary PCI were divided in tow groups of clopidogrel+eptifibatide and ticagrelor. No reflow phenomen after pci was evaluated in two groups.
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with acute chest pain and ST elevation in electrocardiogram
Exclusion criteria
Exclusion criteria: Patients with recent history of using clopidogrel Patients presenting with cardiogenic shock Patients with advanced valvular heart disease Patients who are candidate for urgent cardiac surgery Patients presenting more 12 hours after onset of symptoms
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| No reflow phenomenon. Timepoint: After implantation of stent. Method of measurement: Coronary Angiography views.;ST resolution in EKG. Timepoint: 90 minutes after angiography. Method of measurement: more than 50%decreasing of ST segment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Major and minor bleeding. Timepoint: after pci. Method of measurement: decreasing of Hb and intracranial bleedind and deadly bleeding.;MACCE(mortality and CVA and reMI). Timepoint: after angiography. Method of measurement: the numbering of reMI and CVA and mortality. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Sadeghian
Tehran University of Medical Sciences
Outcome results
None listed